Insider purchases - Last 6 months | Shares | Trans |
---|---|---|
Purchases | 0 | 0 |
Sales | N/A | 0 |
Net shares purchased (sold) | 0 | 0 |
Total insider shares held | N/A | N/A |
% net shares purchased (sold) | N/A | N/A |
Net institutional purchases - Prior quarter to latest quarter | Shares |
---|---|
Net shares purchased (sold) | N/A |
% change in institutional shares held | N/A |
Insider | Transaction | Type | Value | Date | Shares |
---|---|---|---|---|---|
BASKETT FOREST | Sale at price 0.07 per share. | Indirect | 326,257 | 10 Mar 2011 | 4,469,270 |
KERINS PATRICK JOHN | Sale at price 0.07 per share. | Indirect | 326,257 | 10 Mar 2011 | 4,469,270 |
KOLLURI KRISHNA KITTU | Sale at price 0.07 per share. | Indirect | 326,257 | 10 Mar 2011 | 4,469,270 |
DRANT RYAN D | Sale at price 0.07 per share. | Indirect | 326,257 | 10 Mar 2011 | 4,469,270 |
GROWTH EQUITY OPPORTUNITIES FUND L L C | Sale at price 0.07 per share. | Indirect | 326,257 | 10 Mar 2011 | 4,469,270 |
NAGLER DAVID | Stock Gift at price 0.00 per share. | Direct | 0 | 21 Dec 2009 | 1,250 |
ORBIMED ADVISORS, L.L.C. | Sale at price 5.42 per share. | Indirect | 10,848,000 | 22 May 2009 | 2,000,000 |
SIMON NICHOLAS J III | Purchase at price 2.20 per share. | Indirect | 3,932,962 | 14 Nov 2008 | 1,787,710 |
EVNIN LUKE BASIL | Purchase at price 2.20 per share. | Indirect | 3,932,962 | 14 Nov 2008 | 1,787,710 |
ORBIMED ADVISORS, L.L.C. | Purchase at price 2.35 per share. | Indirect | 2,854,428 | 14 Nov 2008 | 1,214,650 |
MPM BIOVENTURES III QP L P | Purchase at price 2.20 per share. | Indirect | 3,932,962 | 14 Nov 2008 | 1,787,710 |
ADELMAN ROBERT J | Purchase at price 2.35 per share. | Indirect | 2,854,428 | 14 Nov 2008 | 1,214,650 |
SIMON NICHOLAS J III | Purchase at price 7.89 per share. | Indirect | 2,367,000 | 13 Nov 2007 | 300,000 |
SIMON NICHOLAS J III | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 3,281,270 |
GODDARD PAUL | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 3,021 |
EVNIN LUKE BASIL | Purchase at price 7.89 per share. | Indirect | 2,367,000 | 13 Nov 2007 | 300,000 |
EVNIN LUKE BASIL | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 3,276,868 |
ORBIMED ADVISORS, L.L.C. | Purchase at price 7.89 per share. | Indirect | 2,367,000 | 13 Nov 2007 | 300,000 |
ORBIMED ADVISORS, L.L.C. | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 1,825,490 |
MPM BIOVENTURES III QP L P | Purchase at price 7.89 per share. | Indirect | 2,367,000 | 13 Nov 2007 | 300,000 |
MPM BIOVENTURES III QP L P | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 3,276,868 |
ADELMAN ROBERT J | Purchase at price 7.89 per share. | Indirect | 2,367,000 | 13 Nov 2007 | 300,000 |
ADELMAN ROBERT J | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 1,825,493 |
DRUZGALA PASCAL | Conversion of Exercise of derivative security at price 0.00 per share. | Direct | 0 | 13 Nov 2007 | 1,122 |
MILNER PETER G | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 47,739 |
NOMURA PHASE4 VENTURES LTD | Conversion of Exercise of derivative security at price 0.00 per share. | Indirect | 0 | 13 Nov 2007 | 2,447,730 |